the bulletin

World Congress for Freedom of Scientific Research the bulletin Number 28, September 2011 Are gene patents eligible? A comment. “A recent ruling by the United States Court of Appeals for the Federal Circuit has reversed a lower court’s decision that Myriad Genetics’ composition of matter claims covering isolated DNA molecules were patent-ineligible products of nature

World Congress for Freedom of Scientific Research the bulletin Number 27, August 2011 Gene Patents Upheld in Myriad Appeal. The new ruling reverses the district court’s decision that Myriad’s composition of matter claims covering isolated DNA molecules were patent-ineligible products of nature under, “since the molecules as claimed do not exist in nature.”  Read the

World Congress for Freedom of Scientific Research the bulletin Number 26, July 2011 A veiled ban on abortion in Russia. “On the 7th of July, Valery Draganov, a member of the Russian Federation’s Chamber of Deputies (Duma), introduced a bill on the “prevention of abortion and support for a child’s life before as well as

World Congress for Freedom of Scientific Research the bulletin Number 25, June 2011 Arab Spring and scientific revival. “The upheaval in multiple Arab countries, known as the “Arab Spring”, is certain to lead to new political structures in a part of the world hitherto dominated by monarchies and dictatorships. But this revolution against autocratic stability

If you have trouble reading this, please click http://www.freedomofresearch.org/bulletin-number-24-May-2011 World Congress for Freedom of Scientific Research the bulletin Number 24, May 2011 The Non-Epistemology of Intelligent Design: Its Implications for Public Policy – A comment by Barbara Forrest. The New York Times has recently reported about a thorny case of censorship on Intelligent Design in

If you have trouble reading this, please click http://www.freedomofresearch.org/sites/default/files/freedom23.html World Congress for Freedom of Scientific Research the bulletin Number 23, April 2011   Embryo’s patentability, your comments. In response to newsletter no. 22, Bernard Siegel, Executive Director and founder of Genetics Policy Institute (GPI), sent his opinion on patentability of biotechnology inventions: “In a sense,

If you have trouble reading this, please click http://www.freedomofresearch.org/article/2011-03-31/news/bulletin/bulletin-number-22-march-2011 World Congress for Freedom of Scientific Research the bulletin Number 22, March 2011 The Hinxton Group issues statement on data/materials sharing and IPR. The Hinxton Group  recently released its third set of recommendations titled “Statement on Policies and Practices Governing Data and Materials Sharing and Intellectual

If you have trouble reading this, please click http://www.freedomofresearch.org/article/2011-02-24/news/bulletin/bulletin-number-21-february-2011 World Congress for Freedom of Scientific Research the bulletin Number 21, February 2011 Hungary and secularism. Following to the open letter sent to the members of the Hungarian Parliament, drawing MPs’ attention on the fact that the draft constitution “if approved in its present version, might